Form 4 for LUNG Pulmonx Corp
Accepted 2023-12-05 00:00:00 ET · period of report 2023-12-01 · accession 0001209191-23-057510 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-12-05 | 2023-12-01 | LUNG | McKune John | Interim CFO | S - Sale | $10.34 | -942 | 40.4K | -2% | -$9,739 |
| 2023-12-05 | 2023-12-01 | LUNG | McKune John | Interim CFO | A - Grant | $0.00 | +7,233 | 47.6K | +18% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-01 | S | D | 222 | $10.34 | 40,999 | D | — | — | |
| 2 | Common | Common Stock | 2023-12-01 | S | D | 135 | $10.33 | 41,221 | D | — | — | |
| 3 | Common | Common Stock | 2023-12-01 | A | A | 7,233 | $0.00 | 47,647 | D | — | — | (F4) Represents grant of the RSUs payable solely in common stock of the Issuer that will become fully vested on December 1, 2024. |
| 4 | Common | Common Stock | 2023-12-01 | S | D | 585 | $10.34 | 40,414 | D | — | — |